Evidence map›Paper›PMID 36945115›Full record

ReviewMolecular genetics & genomic medicine2023

Correlation between large FBN1 deletions and severe cardiovascular phenotype in Marfan syndrome: Analysis of two novel cases and analytical review of the literature.

Gergely Buki, Renata Szalai, Adrienn Pinter, Kinga Hadzsiev, Bela Melegh, Tibor Rauch, Judit Bene

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Molecular genetics & genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gergely BukiDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Renata SzalaiDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Adrienn PinterDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Kinga HadzsievDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Bela MeleghDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Tibor RauchDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pécs, Pécs, Hungary.
Judit BeneDepartment of Medical Genetics, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.ORCID 0000-0001-5757-6244
University of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarfan syndrome (MFS) is a clinically heterogeneous hereditary connective tissue disorder. Severe cardiovascular manifestations (i.e., aortic aneurysm and dissection) are the most life-threatening complications. Most of the cases are caused by mutations, a minor group of which are copy number variations (CNV), in the FBN1 gene.

methodsMultiplex ligation-dependent probe amplification test was performed to detect CNVs in 41 MFS patients not carrying disease-causing mutations in FBN1 gene. Moreover, the association was analyzed between the localization of CNVs, the affected regulatory elements and the cardiovascular phenotypes among all cases known from the literature.

resultsA large two-exon deletion (exon 46 and 47) was identified in two related patients, which was associated with a mild form of cardiovascular phenotype. Severe cardiovascular symptoms were found significantly more frequent in patients with FBN1 large deletion compared to our patients with intragenic small scale FBN1 mutation. Bioinformatic data analyses of regulatory elements located within the FBN1 gene revealed an association between the deletion of STAT3 transcription factor-binding site and cardiovascular symptoms in five out of 25 patients.

conclusionOur study demonstrated that large CNVs are often associated with severe cardiovascular manifestations in MFS and the localization of these CNVs affect the phenotype severity.

Indexed as

Marfan SyndromeAdipokinesDNA Copy Number VariationsFibrillin-1HumansMutationPhenotypeAdipokinesFBN1 protein, humanFibrillin-1cardiovascular manifestationFBN1large deletionMarfan syndromeregulatory DNA

Identifiers

PMID36945115
PMCPMC10337287
OpenAlexW4353021657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.